| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |